Geovax Labs Inc. Insider Trading

GOVX

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Oct 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Oct 2025

Oct 17, 2025

Get an email when GOVX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 17, 2025	John N Spencer Jr Director	Bought	10,000	$0.55	6K	88%	Form 4
Aug 7, 2025	Kelly T. McKee Jr. Chief Medical Officer	Bought	1,107	$0.67	$742	46%	Form 4
Apr 10, 2025	John N Spencer Jr Director	Bought	10,000	$0.98	10K	713%	Form 4
Apr 10, 2025	John W. Sharkey VP, Business Development	Bought	6,000	$0.99	6K	3141%	Form 4
Apr 1, 2025	David A Dodd President, CEO	Bought	10,000	$1.08	11K	38%	Form 4
Mar 31, 2025	Mark Reynolds CFO	Bought	6,800	$1.08	7K	94%	Form 4

Oct 17, 2025
John N Spencer Jr
Director · bought 10,000 at $0.55
6K
88% of stake
Aug 7, 2025
Kelly T. McKee Jr.
Chief Medical Officer · bought 1,107 at $0.67
$742
46% of stake
Apr 10, 2025
John N Spencer Jr
Director · bought 10,000 at $0.98
10K
713% of stake
Apr 10, 2025
John W. Sharkey
VP, Business Development · bought 6,000 at $0.99
6K
3141% of stake
Apr 1, 2025
David A Dodd
President, CEO · bought 10,000 at $1.08
11K
38% of stake
Mar 31, 2025
Mark Reynolds
CFO · bought 6,800 at $1.08
7K
94% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GOVX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with GOVX

CompareIntrinsic value

OPKOpko Health Inc.

$1.77+2.91%25

JNJJohnson & Johnson

$276.34+3.82%53

BMRNBiomarin Pharmaceutical Inc.

$57.13+2.64%47

BFRIBiofrontera Inc.

$0.90+1.55%30

BGMBGM Group Ltd.

$8.81-7.65%26

TGTXTG Therapeutics, Inc.

$61.63+1.45%57

RAREUltragenyx Pharmaceutical Inc.

$17.16+3.19%40

IDYAIdeaya Biosciences Inc.

$32.36+3.29%40

Spot a number that looks wrong? Check it in GOVX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GOVX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.